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ABSTRACT 
Indian toad (Bufo melanostictus) skin extract (TSE) was evaluated for cytotoxic and apoptogenic activities on Ehrlich ascites 
carcinoma (EAC) cells of EAC bearing Swiss albino male mice. LD50 of TSE was found to be 400 mg kg-1, (i.v.) and 750 mg kg-1, 
(i.p.) in mice. EAC cells (1-2  105 / mouse) were inoculated (i.p.) into mice (20.6  0.14 gm) and proliferation and viability of EAC 
cell were determined in TSE treated and control groups. TSE (10, 20, 30 mg kg-1 d-1, i.p. for 10 d) significantly inhibit EAC cell 
growth in dose dependent manner. TSE (50, 100 mg kg-1 d-1, i.p. for 1 d) significantly reduced the viability of EAC cells and 
decreased the MTT values compared to control cells. TSE induced DNA breakage was reflected in DNA ladder and single cell gel 
electrophoresis (comet assay). TSE significantly (P<0.001) increased the number tailed cells and length-width ratio of DNA mass in 
EAC cells as compared to control. Fluorescent microscopy of TSE treated cells showed significant increase in number of early and 
late apoptotic cells compared to the control EAC cells. Apoptotic index of TSE treated cells was significantly (P<0.001) higher than 
that of the control cells. Changes in serum LDH, β2-microglobulin in TSE treated EAC mice and our earlier studies indicated the 
involvement of immunomodulation which may indirectly be associated with the anticancer activity of TSE.  
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1. INTRODUCTION 
Cancer, the second killer disease of the world and its 
management is a major socio-medical problem. 
Although, several chemotherapeutic approaches have 
been taken to tackle the complexity of different cancer, 
the incidence and mortality rate for most form of cancer 
still remain high. Toxicity and resistance may represent 
the potential obstacles to successful clinical 
development. Search for novel and safe drug from 
natural plant products are ventured worldwide, which 
are showing promising results. Very few animal sources 
are under research as therapeutics of malignancies; toad 
skin component is one of them. The toad, though ugly 
and venomous, wear yet a number of precious bioactive 
jewels in the skin. Several host defence peptides are 
highly selective towards cancer cells whereas, they have 
no toxicity on normal mammalian cells. These peptides 
generally have diverse structural array, cationic nature 
and a large portion of hydrophobic amino acids 
1
. The 
skin secretion of toad or/and frog has been used in 
therapeutic purposes by many different cultures around 
the world. Toads are well-known to be an affluent 
source of granular gland secretions, containing large 
amount of biogenicamines, alkaloids, steroids, peptides 
and proteins 
2-4
. These diverse biomolecules play a 
potent character in the molecular drug development for 
pharmacological and toxicological evaluations and even 
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for drug synthesis and medicinal chemistry 
5
. Previously, 
it was bring into being that the skin extract of Bufo asper 
have significant antimicrobial activity. From the 
proteomic study of the skin secretions, 50 proteins were 
identified having molecular weight between 20 to 250 
kDa 
6
.  In traditional Chinese medicine toad skin is used 
in human therapy and widely applied in China, Japan, 
Korea and other Asian countries as an alternative 
medicine 
7, 8
. Many studies have reported that toad skin 
extract and its components can inhibit cancer cell 
growth, migration and invasion via different 
mechanisms 
9-11
. The Chinese frog, ‘Chan sue’ is used as 
a cardiotonic agent, treating arrthythmia and other heart 
diseases and certain cancer 
7, 12. ‘Kyushin’ is a 
traditional Chinese medicine (Chan sue) frequently used 
in Japan and it has demonstrated digoxin like effects 
13
. 
The anticancer activities of frog and toad skin have 
recently been investigated 
14, 15
. Very few studies on the 
anticancer activities of Indian toad skin extract have 
been reported till date. Earlier report from the present 
laboratory, suggested that the Indian toad (Bufo 
melanostictus) skin extract reduces EAC cell growth and 
possess immunomodulatory activity 
16
. Another report 
from our laboratory confirmed the fact that an active 
component of skin extract of Indian toad (Bufo 
melanostictus) (BM-ANF1) showed dose-dependent 
inhibition of U937, K562 and HepG2 cell proliferation 
arresting at G1 phase of the cell cycle 
17,18
. An additional 
research from this laboratory established the fact that, 
BM-ANF1 in combination with curcumin exerts a 
marked inhibition of colon cancer proliferation 
19
. 
Furthermore, a low immunogenic protein toxin (BMP1) 
showed anticancer activity against EAC bearing mice, 
leukemic and hepatoma cells 
20, 21
  The present study 
reports the cytotoxic and apoptogenic properties of 
Indian toad skin extract (TSE) on Ehrlich ascites 
carcinoma (EAC) cells of the experimental EAC bearing 
mice. 
2. MATERIALS & METHODS 
2.1. Chemicals used  
Acridine orange (Sigma, USA), DMSO (SRL, India), 
EDTA (Sigma, USA), Ethidium bromide (Sigma, USA), 
RPMI (GIBCO BRL,
 
USA),Fetal bovine serum 
(GIBCO,
 
BRL, USA), Penicillin-streptomycin (Biowest, 
Germany), Gentamicin (Nicholas, India), Heparin 
(Sigma, USA), Low melting point agarose (Promega, 
USA), Methanol (Spectrochem, India), MTT (Sigma, 
USA), Normal melting point agarose (Promega, USA), 
Triton X-100 (SRL, India), Trypan blue (SRL, India).  
2.2. Animals used 
Male albino mice (Swiss strain) having body weight 
20.6  0.14 gm were used for the experiments. The 
animals were housed in the departmental animal house 
(22  2oC, 60  5% relative humidity) with food (Pellet, 
Ashirbad Industries, Chandigarh, India), soaked gram, 
water ad libitum  and 12-12 h light and dark cycle. 
Animal experiments were approved by the Institutional 
Animal Ethics Committee (IAEC) and they were 
handled as per the guidelines in accordance with the 
Committee for the Purpose of Control and Supervision 
of Experiments on Animals (CPCSEA), Government of 
India. 
2.3. Collection and preparation of Toad skin extract 
(TSE)  
Adult toads (Bufo melanostictus, Schneider) of both 
sexes (80-100gm) were procured from M/S Reeta Ghosh 
& Company, Calcutta, India. Skin was collected from 
freshly pithed toads, washed in distilled water and kept 
immersed in methanol at room temperature for 30-40 
days. The methanolic extract was then filtered, 
evaporated to become dry by rotary evaporator and the 
extract was stored at room temperature in a desiccator. 
The yield of the extract was 1.3  0.46 % and was 
expressed in terms of dry weight. The extract (TSE) was 
suspended in 0.9% saline / phosphate buffer saline (pH 
7.2) for the experiments.  
2.4. Toxicity of TSE 
Different concentrations (100, 200, 300, 400, 500, 600, 
700, 800 mg kg
-1
) of TSE were administered (i.v. / i.p.) 
in Swiss male albino mice (20-22 gm) and LD50 value 
was detected by plotting the mortality percentage of 
animals against the doses 
16
.    
2.5. Transportation and maintainance of Ehrlich Ascites 
Carcinoma (EAC) Cells 
Ehrlich ascites carcinoma (EAC) cells were collected 
from tumour bearing Swiss male albino mice at their 
respective log phase of growth. It was a gift from Indian 
Institute of Chemical Biology, Kolkata, India. A 5 ml 
syringe fitted with 20-gauge needle was used for this 
tumour cell aspiration. The freshly drawn fluid was 
diluted with phosphate buffer saline (PBS) (pH 7.4) and 
the number of tumor cells was adjusted to 1106 cells 
ml
-1
 by counting with a haemocytometer. The viability 
of tumour cells was checked by Trypan blue dye (0.4%) 
exclusion assay. Cell samples showing above 90% 
viability were used for transplantation. 0.1 ml of such 
suspension was injected intraperitoneally to each Swiss 
male mice. Aseptic condition was maintained throughout 
the transplantation process. The EAC cells were 
maintained with sub culturing each week.  
2.6. EAC cell growth inhibition 
Animals were inoculated (i.p.) with 0.1 ml of 2  105 
cells mouse
-1
 on day zero and TSE treatment was started 
after 24 hours of inoculation at the doses of 10, 20, 30 
mg kg
-1
 d
-1
, i.p. for 10 days. The control group was 
treated with the same volume of 0.9% saline. 5FU (10 
mg kg
-1
 d
-1
, i.p. for 10 days) was taken as standard. All 
the treatments were continued for 10 days. On the 11
th
 
day after transplantation, all the animals were sacrificed 
and tumour cells were collected by repeated 
intraperitoneal washing with phosphate buffer saline (pH 
7.2). Tumour cell count was made from treated group 
and it was compared with that of the control group 
23
. 
2.7. EAC cells viability assay 
The procedure was a modification of the method of 
Fernandes and Klubes (1979) 
22-23
. Control, treated and 
standard groups of mice (6 mice in each group) were 
inoculated with 0.1 ml of 2105 EAC cells on day zero. 
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On second day after intraperitoneal inoculation with 
EAC cells, mice received either (a) 0.9% saline (b) Toad 
skin extract (TSE) at a dose of (50, 100 mg kg
-1
 d
-1
, i.p. 
for 1 d) and (c) 5FU (50 mg kg
-1
 d
-1
, i.p. for 1 d). 24 
hour after treatment, tumour cells from each group of 
mice were counted and harvested in cold saline, pooled, 
centrifuged and reinoculated (0.1 ml of 2105 cells/ 
mouse) intraperitoneally into three groups containing 6 
mice in each group. On the day seven after 
reinoculation, all experimental animals from each group 
were sacrificed and tumour cell count of each mice was 
estimated. 
2.8. MTT assay  
The chemosensitivity of the EAC cells from control 
(0.9% saline), treated (TSE 20, 30 mg kg
-1
 d
-1 
, i.p. for 5 
days) and standard (5-FU, 10 mg kg
-1
 d
-1
, i.p. for 5 days) 
group mice was determined by a quantitative 
colorimetric assay using 3-(4,5-dimethylthiazol-2-yl)-
2,5,-diphenyltetrazolium bromide (MTT). The assay is 
based on the reduction of Tetrazolium salt by the 
mitochondrial dehydrogenase enzyme of intact cells to a 
purple formazan product 
24
. The OD was recorded at 570 
nm by a microtiter plate reader (Merck-MIOS mini, 
Model no.309). 
2.9. Alkaline Comet assay  
The alkaline comet assay of EAC cells was performed 
after TSE (30 mg kg
-1
 d
-1
, i.p. for 5 days) treatment in 
treated group and saline (0.9%) treated control group 
16, 
25
. In brief, clean microscope glass slides were covered 
with 400µl of 0.75% normal melting point (NMP) 
agarose (Qualigen) in PBS pre warmed at 50
0
C. A cover 
glass was positioned over the agarose solution, and 
allowed to be solidified. Then 85µl of cell-low melting 
point agarose (LMP) solution was placed over the first 
agarose layer and allowed to solidify under a clean cover 
glass. 100µl of 0.5% low melting point agarose was 
added further on NMP agarose layer again under a cover 
glass and allow to solidify at 4
0
C. The slides were 
tenderly immersed in a freshly prepared cold lysis buffer 
(2.5 M NaCl, 100 mM EDTA, 10mM Tris, 10% 
dimethyl sulfoxide and 1% Triton X-100, pH adjusted to 
10 with NaOH) and kept at 4
0
C in the dark for 1 h. The 
slides were placed to the horizontal gel electrophoresis 
unit filled with fresh, cold electrophoresis buffer 
(300mM NaOH, 1mM EDTA, pH 13.5) for 20 min. 
Electrophoresis was conducted at 20Volt 
(1.0V/cm,175mA) for the next 20 min. The slides were 
then drained, and flooded slowly with three changes of 
neutralization buffer (0.4M Tris-HCl, pH 7.5), each for 5 
min. The slides were stained with Ethidium bromide 
(10µg ml
-1
), covered with a cover glass, and analyzed 
within 10 min at 100X magnification using a fluorescent 
microscope (Motic, Germany) with green filter. The 
photographs were taken through the attached CCD 
camera. The comet scores were recorded by random 
counting about 100 cells per slide, considering no 
overlap of counting and the DNA comet tail length and 
width was measured using Motic Images Plus 2.0 
software. 
2.10. DNA fragmentation study by ladder formation   
EAC cells were quantitatively collected in TSE (30 mg 
kg
-1
 d
-1
, i.p. for 5 days) treated and saline (0.9%) control 
group. It was then washed with cold phosphate buffer 
saline (pH 7.4) two to three times and fixed with 70% 
ethanol. The cells were then lysed with 1.2 ml of SDS
 
lysis buffer (10 mM Tris·HCl, 10 mM EDTA, 100 mM 
NaCl, 2% SDS,
 
pH 8.0) containing 20 µL Proteinase K 
(20mg/ml) and incubated in a water bath at 56
0
C 
overnight. Next day lysate was centrifuged and extracted 
with an equal volume of phenol: chloroform: isoamyl 
alcohol (25:24:1) and
 
recovered by ethanol–sodium 
aetate precipitation. The nucleic acid pellet
 
was 
dissolved in 200µL of Tris-EDTA buffer (10 mM Tris-
HCl,10 mM EDTA),
 
adjusted to 1 µg ml
-1
 RNase A, and 
incubated for 10 min
 
at 37°C. DNA was then recovered 
by phenol extraction and ethanol
 
precipitation. The final 
DNA concentration was determined by
 
the optical 
density at 260 nm. The DNA chain break was analyzed 
by agarose gel electrophoresis with the 2 % gel and 
stained with ethidium bromide 
26
. 
2.11. Fluorescent microscopy   
The EAC inoculated mice were divided into two groups. 
In one group, TSE (30 mg kg
-1
 d
-1
, i.p.) was treated for 5 
days. Second group was considered as saline (0.9%) 
control. After 24 h of the last treatment, the control and 
TSE treated cells were washed with chilled PBS (pH 
7.2) and the stained with ethidium bromide and acridine 
orange (100 mg ml
-1
 each in PBS). The apoptotic cells 
could be visualized by acridine orange while the viable 
and nonviable cells could be differentiated by ethidium 
bromide. Two hundred cells were counted and the 
cellular states were recorded. The apoptotic index was 
calculated using the following formula 
27
.  
Apoptotic index = (Apoptotic cells/ Total cells) 100 
2.12. Serum LDH and 2-microglobulin of EAC bearing 
mice 
Swiss albino Male mice (201 gm) were divided into 
four groups (Group 1-Normal control, Group 2- EAC 
control, Group 3- TSE control and Group 4-EAC + TSE 
treated) in two sets (I & II).  
After inoculating with EAC cells, 3
rd
 and 4
th
 group were 
treatment with TSE (20 mg kg
-1
 d
-1
, i.p.) and the 
treatment continued for 7
 
days in set I and for 15 days in 
set II. Blood was collected aseptically from the retro-
orbital plexus of mice and the following experiment was 
carried out in both the sets.   Serum level of 2-
microglobulin and lactate dehydrogenase (LDH) was 
estimated in all the groups of animals by enzymatic 
kinetic procedure using commercial kits (Boehringer-
Manheim) and automated biochemical analyzer 
(Hitachi).   
2.13. Statistical analysis 
Values were expressed as mean  SEM. Statistical 
analysis was done by one way Anova test and Student’s 
t test, P<0.05 was considered significant. n = 6 in all the 
animal experiments, unless otherwise mentioned.  
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3. RESULTS 
3.1. Toxicity of TSE    
LD50 of TSE was found to be 400 mg kg
-1
 (i.v.) and 750 
mg kg
-1
 (i.p.) in male albino mice. 
3.2. Tumour cell growth inhibition 
Mean percentile inhibition of EAC cell count after 
treatment with TSE (10 mg kg
-1
 d
-1
, 20 mg kg
-1
 d
-1
and 30 
mg kg
-1
 d
-1
, i.p. for 10days) treated groups were 33.1%, 
51.4% and 73.2% respectively as compared to the 
control. Where as standard 5-FU (10 mg kg
-1
 d
-1
, i.p., for 
10 days) produced 55.2% inhibition of EAC cell count 
compared to control (Fig 1, Table 1) 
 
Table 1: Effect of TSE on Body weight, EAC cell growth, EAC cell viability, Tumor volume, MTT value of EAC 
bearing mice. 
________________________________________________________________________________________________ 
Parameters                                      EAC             TSE               TSE             TSE               5-FU 
                                                      Control      (10mg/Kg)    (20mg/Kg)      (30mg/Kg)     (10mg/Kg) 
                                                                          + EAC           + EAC          + EAC            + EAC 
Body weight (g)                          28.60.17     26.40.13     24.50.18a       23.10.17b         22.40.12b 
EAC cell count (106)                23.50.56     15.70.42b    11.4 0.37c       6.30.23c          10.50.31c 
Mean percentile inhibition              00.0             33.1              51.4               73.2                   55.2      
of EAC cell growth (%)  
EAC cell viablity (count106)   14.40.43       11.70.29a      8.90.16c           --                    9.80.12c            
*Reduction in viability (%)            00.0             18.5              38.0                   --                     31.4 
Tumor volume (ml)                    4.700.11       4.120.08     3.540.06a        2.200.03b        1.840.07c 
MTT value (OD at 570nm)        0.1040.002       --               0.0680.006b    0.0430.002c    0.0690.005 c   
Reduction in MTT value(%)          00.0               --                 21.9                 34.6                   35.3 
Values are expressed as Mean  SEM, n=6, aP<0.05, bP<0.01, cP<0.001, TSE treated groups compared with EAC control group. 
*Viability was done at the dose of 50mg/Kg and 100 mg/Kg TSE  and 50mg/Kg 5-FU, per day for 1 day, i.p. (Body weight of 
normal mice was 20.6  0.14) 
 
 
Figure 1: Effect of TSE on EAC cell growth inhibition of EAC bearing mice. 
bP<0.01, cP<0.001, significant. 
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3.3. EAC cell viability 
TSE treatment significantly decreased the EAC-cell 
viability. On 7
th
 day after reinoculation the TSE (50 and 
100 mg kg
-1
 d
-1 
, i.p. for 1 d) treated group showed 
18.5% (P<0.05) and 38.0% (P<0.01) significant 
reduction in viability of EAC cells respectively 
compared to the control. Where as standard 5-FU (10 
mg kg
-1
 d
-1
, i.p., for 1 d) reduced the viability of EAC 
cells was about 31.4% (P<0.01) (Fig.2 ,Table 1). 
 
 
Figure 2: Effect of TSE on EAC cell viability of EAC bearing mice. 
aP<0.05, cP<0.001, significant. 
3.4. MTT assay 
It was observed at 7
th
 day that, standard 5 FU (10 mg kg
-
1
 d
-1
, i.p. for 5 days) could be able to reduced the MTT 
value of about 35.3% and TSE (20 and 30 mg kg
-1
 d
-1
, 
i.p. for 5 days) showed 21.9 % and 34.6 % reduction in 
OD value respectively as compared with untreated 
control EAC cells. The OD of TSE treated cells was 
significantly greater than the control (Fig.3, Table 1). 
 
 
Figure 3: Effect of TSE on MTT assay of EAC cells. 
bP<0.01, cP<0.001, significant. 
3.5. Alkaline Comet assay 
Mean number of tailed cells (TC) (%) and mean of 
length:width ratios (L:W) were analyzed in control and 
TSE treated (30 mg kg
-1
 d
-1
, i.p. for 5days) EAC cells at 
7
th
  days of tumour cell inoculation. The mean length to 
width ratio of the DNA mass observed in TSE treated 
EAC cells was significantly greater (P<0.001) compared 
to that of normal control cells. The mean length-width 
ratio of control cells was 1.14  0.06 where as in TSE 
treated EAC cells, the ratio was 2.27  0.10.  Similarly, 
the mean frequency of tailed cells was (92.40.26) in 
TSE treated EAC cells, which was significantly different 
(P<0.001) from the normal control (8.7  0.13) (Fig 4, 
Table 2). 
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Table 2: Effect of TSE on the single cell electrophoresis of EAC cells 
Cell Groups                           Tailed Cells (%)                    Length-width ratio 
EAC Control (0.9% Saline)                                        7.5  0.08                                 1.23  0.035  
TSE (30mg/Kg/day for 5days)                                   91.0  0.25*                              2.12  0.104*  
*P<0.001, significant 
 
       
 
Figure 4: Effect of TSE on alkaline comet assay of EAC cells. 
A = EAC control cells, B = TSE treated EAC cells 
 
3.6. DNA fragmentation study by ladder formation assay  
TSE (30 mg kg
-1
 d
-1
, i.p. for 5 days) produced ladder type of DNA fragmentation in Ehrlich ascites carcinoma cells 
where as control cells produced single DNA band on the agarose gel (Fig.5). 
 
Figure 5: Effect of TSE on DNA fragmentation of EAC cells 
C = DNA of EAC control, T = DNA of TSE treated EAC cells. 
 
 
B 
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3.7. Fluorescent microscopy 
TSE (30 mg kg
-1
 d
-1
, i.p. for 5 days) treatment produced 
16.5%0.24 live cells with normal nuclei (LN), 
43.5%0.28 apoptotic cells (A), 13.0%0.19 dead cells 
with normal nuclei (DN) and 26.5%0.31 dead cells 
with apoptotic nuclei (DA). Whereas the control EAC 
cells showed 85.5%0.34 live cells with normal nuclei, 
6.0%0.13 apoptotic cells, 5.5%0.10 dead cells with 
normal nuclei and 3.0%0.05 dead cells with apoptotic 
nuclei (Fig. 6, Table 3). The apoptotic index in TSE 
treated EAC cells was 69.7 whereas the apoptotic index 
of control EAC cells was 9.0 (Table 4). 
 
     
Figure 6: Effect of TSE on fluorescent microscopic analysis of EAC cells 
A = Control EAC cells, B = TSE treated EAC cells 
Table 3: Effect of TSE on cell architecture modulation and apoptosis induction on EAC cells 
Cell architecture    EAC Control (0.9% Saline)    TSE (30mg/Kg/day for 5days)  
                                                                           Cells (%)                       Treated EAC cells (%) 
Live cells with normal nuclei (LN)        85.5        16.5 
Apoptotic cells (A)                      06.0        43.5 
Dead cells with normal nuclei (DN)       05.5        13.0 
Dead cells with apoptotic nuclei (DA)       03.0        26.5 
Total cell counted = 200 
Table 4: Effect of TSE on apoptotic index of EAC cells 
Cell Groups                  Total cells         Apoptotic cells           Apoptotic index              
EAC Control (0.9% Saline)                                  200                  18.0  0.47                       9.0 
TSE (30mg/Kg/day for 5 days)                        200                 139.4  1.06*                    69.7 
Apoptotic index = Number of apoptotic cells/ Total cells (100), *P<0.001, significant 
 
3.8. Serum LDH and 2-microglobulin of EAC bearing 
mice 
The serum biochemical analysis of EAC bearing mice 
revealed that TSE (20 mg kg
-1
 d
-1
, i.p., for 7 days and 15 
days) showed that the LDH level was significantly 
increased in TSE treated group at 7 days as compared 
with normal control as well as EAC bearing mice but at 
15 days it came towards normal. The serum 2-
microglobulin level also significantly increased in TSE 
treated EAC bearing mice at 7
th
 day. The raised 2-
microglobulin level came towards normal and no 
significant different was observed at 15
th
 day (Table 5). 
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Table 5: Effect of TSE on serum LDH and 2-microglobulin level of EAC bearing mice. 
Mice group                                                  LDH level (U/L)         2-microglobulin (mg/L) 
Normal control                                             3760.28*                        1.8  0.06* 
EAC control                                                 3840.42                          2.1  0.08 
TSE control                                                  3910.37                          2.0  0.10 
EAC + TSE treated (7
th
 day)                        4160.54*a                      3.2  0.05*b     
EAC + TSE treated (15
th
 day)                      3890.48                                     2.2  0.07 
*aP<0.05, *bP<0.01, significant 
4. DISCUSSION  
The present investigation demonstrated that the Indian 
toad (Bufo melanostictus) skin extract (TSE) 
significantly inhibits Ehrlich ascites carcinoma cells 
growth in EAC bearing Swiss albino mice in a dose (20, 
30, 40 mg kg
-1
 d
-1
) dependent manner. TSE not only 
reduced the EAC cell count, it also decreased the 
accumulation of ascites fluid in the peritoneum and 
increased the percentage of dead cells as observed in 
trypan blue dye exclusion study.  The viability of cancer 
cells also significantly decreased dose dependently. 
Earlier study from this laboratory showed that TSE 
significantly increased the life span of EAC bearing 
mice 
16
. In the present study, TSE significantly reduced 
the MTT values in cancer cells as compared to control in 
both 50 and 100 mg/Kg of doses. MTT assay is the most 
common assay employed for the detection of 
cytotoxicity or viability following the exposure of 
cytotoxic substances. MTT assay shows more sensitivity 
in detecting early cytotoxicity compared to the LDH 
leakage assay and other assay 
28
. The cytotoxic and 
antiproliferative drugs may disrupt the mitochondrial 
succinate dehydrogenase system thus reduces the MTT 
value. In the present study, the reduced MTT values and 
reduced viability of EAC cells by the TSE is mainly due 
to its antiproliferative and cytotoxic nature. It is also 
evident that TSE induce apoptosis in various human 
cancer cell lines such as T24 human bladder carcinoma 
cells, A549 human lung carcinoma, HepG2 
hepatocarcinoma cells, SP53 mantle cell lymphoma and 
non-Hodgkin's lymphoma 
29-31
. In this study, comet 
assay is employed for the detection of different 
genotoxic agent and also be utilized for the 
determination of DNA fragmentation in the apoptotic 
cells. As the extent of apoptosis increases, the tail 
movement and tail length of the comet formed increases, 
which are correlated with the degree of DNA damage 
32
.  
Here, TSE induced DNA fragmentation was observed in 
single cell gel electrophoresis. TSE produced significant 
increase in length width ratio in EAC cells as compared 
to the control (Fig 5, Table 2). This is due to the 
movement of fragmented DNA mass of the apoptotic 
tumor cells during electrophoresis. In apoptotic cells 
there are approximately 60,000 DNA strand breaks 
generated per cell 
33
. With the comet assay, 100 DNA 
strand breaks per cell are sufficient for DNA damage to 
be detected 
34
. The TSE induced ladder pattern of DNA 
fragmentation in the agarose gel again supported its 
apoptogenic activity. DNA fragmentation at 180-200 bp 
by endonuclease is the most characteristic phenomena of 
apoptosis 
33
. DNA fragmentation produces a ladder 
pattern of arrangement reflected in agarose gel 
electrophoresis, thus employed for the detection of 
apoptosis. Observation on the studies on Chinese toad 
(Bufo Bufo gargarizans) skin preparation (Chan Sue) 
with flow cytometry, agarose gel electrophoresis of 
DNA and fluorescent staining in human bladder 
carcinoma cell line, indicated its apoptogenic nature 
29
. 
Chan Sue induced apoptosis in human leukemic cells 
(U937) was also reported 
35
. In previous study from our 
lab it has already been reported that TSE of Indian toad 
exert significant antiproliferative, cytotoxic and 
apoptogenic activities on U937 and K562 leukemic cell 
lines. Microscopic observations of the altered 
fragmented nuclei, formation of apoptotic bodies, 
cellular membrane blebbing and cell surface shrinkage 
in TSE treated leukemic cells strongly support the 
apoptogenic properties of TSE of Indian common toad 
17
. Here the apoptotic, necrotic and dead cells were 
detected and counted in the fluorescent microscope with 
acridine orange – ethidium bromide double staining. 
The double staining of the EAC cells indicated that TSE 
produced significantly greater number of apoptotic cells 
as compared to control (Fig 6). The calculated apoptotic 
index due to TSE in EAC cells was significantly high as 
compared to control. From these observations it may be 
opined that the EAC cell growth inhibition, reduced 
viability and reduced MTT values in the TSE treated 
cancer cells is associated with its antiproliferative and 
cytotoxic nature and the increased comet length-width 
ratio, DNA ladder formation and the increased apoptotic 
index indicated the apoptogenic nature of TSE.  
Interestingly, the serum lactate dehydrogenase (LDH) 
level was significantly increased in TSE treated EAC 
bearing mice at 7
th
 day but it returned towards normal at 
15
th
 day of treatment. It has been reported that LDH is 
generally elevated in patients with certain aggressive 
malignancies 
36
. Though, initially TSE treated EAC 
mice showed elevated LDH level, continued treatment 
restore the LDH level, which was supported and 
correlated with the cancer progression arrest in EAC 
bearing mice. 2-microglobulin level has been found to 
correlate with the tumour growth and progression 
kinetics 
37, 38
. TSE mediated restoration of elevated 2-
microglobulin at 15 days indicated that TSE might 
reduced the tumour burden or tumour progression. 
Again, LDH uplifting agent is responsible for interferon 
induction and enhancement of natural killer cell activity 
by inoculation of Ehrlich ascites carcinoma cells into 
mice 
39
. Interferon- and NK-cells inducing agents have 
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anticancer activity on renal cell carcinoma in mice 
40
. 
Interferon (IFN-) may activate macrophage which in 
turn up and regulate the MHC II molecule 
41
. The TSE 
induced elevation of 2-microglobulin further supported 
the involvement of MHC I molecule in the TSE induced 
antitumor and immunomodulatory activities. The rise in 
serum 2-microglobulin is related to the 
immunomodulation properties of interferon 
42
. MHC 
plays a central role in the development of both humoral 
and cell-mediated immune responses. The class I MHC 
 chain expression level on cell membrane suppressed 
in absence of 2-microglobulin. It is evidenced in Daudi 
tumour cells which do not synthesize 2-microglobulin 
43
. Previous report from this laboratory have 
demonstrated that Indian toad  (Bufo melanostictus) skin 
extract increased peritoneal macrophage count, reduced 
carbon clearance time from blood and increased 
lymphocyte chemotaxis in EAC bearing mice 
16
. From 
this result it was presumed that TSE may be involved in 
the induction of interferon and NK-cell, which in turn 
involved in the macrophage mediated antitumour 
activity and the induction of cell mediated immunity. It 
is widely recognized that macrophages are one of the 
major effector cells in the anti-tumor immune defense 
system of the host. There are certain reports that 
macrophage activating agent exerts antitumour activity 
against wide variety of tumours 
44
. It has been evident 
that chemotherapy in association with immunotherapy 
produced better results against cancer and showed lesser 
resistance against drug 
45-47
. The present investigation 
suggested that toad skin extract (TSE) induced 
immunomodulatory activity may be associated with its 
antitumour activity. 
It may be concluded that Indian toad (Bufo 
melanostictus) skin extract possess antiproliferative, 
cytotoxic and apoptogenic activity on Ehrlich ascites 
carcinoma (EAC) cells of EAC bearing mice, which 
may be connected with its immunomodulatory activity. 
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